US Stocks
/
Xilio Therapeutics, Inc. Share Price

Xilio Therapeutics, Inc. Share Price

NASDAQ: XLO | Micro Cap
$8.93
-$0.09 (-1%) Last updated on 18 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Xilio Therapeutics, Inc. Stock Performance

Open
$9.00
Prev. Close
$9.02
Circuit Range
N/A
Day Range
$9.00 - $9.00
Year Range
$0.47 - $9.75
Volume
180
Average Traded
$9.00

Xilio Therapeutics, Inc. Share Price Today

As of 18 September 2026, Xilio Therapeutics, Inc.'s share price is $8.93. The stock opened at $9.00, compared to its previous close of $9.02. During today's trading session, Xilio Therapeutics, Inc.'s share price traded between $9.00 and $9.00, with an average price of $9.00. Over the past 52 weeks, the stock has recorded a high of $9.75 and a low of $0.47. In terms of performance, Xilio Therapeutics, Inc.'s share price has risen by 5.43% over the last six months and is up 937.17% on a year-on-year basis.

Xilio Therapeutics, Inc. Share Price Chart

$9.00$9.00
L
Show Current Price
H

Xilio Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$74.65M
PE Ratio (TTM)
-2.13
Dividend Yield
N/A
EPS (TTM)
$-4.19
Revenue (TTM)
$43.77M
Return On Equity (TTM)
-165.11%
Profit Margin
-133.07%
Debt to Equity
1.60
Quarterly Earnings Growth YoY
N/A

Xilio Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$2.36M$2.26M$2.93M$8.08M$19.07M
Net Profit-$17.20M-$13.93M-$14.02M-$13.27MN/AN/A
Net Profit MarginN/A-590.79%-619.53%-452.73%N/AN/A
Income ChangeN/A19.05%-0.68%5.39%N/AN/A

Xilio Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
RevenueN/A$6.34M$43.77M
Net Profit-$76.40M-$58.24MN/A
Net Profit MarginN/A-918.05%N/A
Income ChangeN/A23.77%N/A

About Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Xilio Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$9.05
$9.00
-1.59%
Aug 2026
$9.18
$9.14
-0.27%
Jul 2026
$9.08
$9.17
-3.22%
Jun 2026
$8.43
$9.47
+11.80%
May 2026
$8.43
$8.47
+6.47%
Apr 2026
$8.58
$7.96
-6.02%
Mar 2026
$0.52
$8.47
+1,495.10%
Feb 2026
$0.58
$0.53
-10.30%
Jan 2026
$0.64
$0.59
-7.93%
Dec 2025
$0.75
$0.64
-14.49%
Nov 2025
$0.82
$0.75
-5.41%
Oct 2025
$0.84
$0.80
-7.67%

XLO Share Price FAQs

What is Xilio Therapeutics, Inc. share price today?

chevron-up
Xilio Therapeutics, Inc. share price today is $8.93 as on September 18, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Xilio Therapeutics, Inc. stock?

chevron-up
The 52 week high of Xilio Therapeutics, Inc. stock is $9.75, while the 52 week low is $0.47 as of 18 Sep '26.

What is XLO's market capitalisation today?

chevron-up
XLO market capitalisation is $74.65M as of September 18, 2026, at 4:43 pm IST.

What is the 5 year returns of XLO?

chevron-up
The 5 year returns of XLO is -46.81% as on 18 Sep '26.

What is the high & low stock price of XLO today?

chevron-up
XLO stock price hit a high of $9.00 and low of $9.00 as of 18 Sep '26.

Can I buy XLO shares in India?

chevron-up
Yes. You can buy XLO in India by opening an international trading account.